BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 56 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $975,869 | +267.1% | 950,000 | +280.0% | 0.00% | – |
Q4 2022 | $265,828 | -42.1% | 250,000 | -45.8% | 0.00% | – |
Q3 2022 | $459,000 | +3.1% | 461,000 | +2.4% | 0.00% | – |
Q2 2022 | $445,000 | -1.8% | 450,000 | 0.0% | 0.00% | – |
Q1 2022 | $453,000 | -4.2% | 450,000 | 0.0% | 0.00% | – |
Q4 2021 | $473,000 | -45.8% | 450,000 | -47.1% | 0.00% | – |
Q3 2021 | $873,000 | -1.4% | 850,000 | 0.0% | 0.00% | – |
Q2 2021 | $885,000 | +1.7% | 850,000 | 0.0% | 0.00% | – |
Q1 2021 | $870,000 | -5.0% | 850,000 | 0.0% | 0.00% | – |
Q4 2020 | $916,000 | +3.2% | 850,000 | 0.0% | 0.00% | – |
Q3 2020 | $888,000 | -14.9% | 850,000 | 0.0% | 0.00% | – |
Q2 2020 | $1,043,000 | +121.9% | 850,000 | +88.9% | 0.00% | – |
Q1 2020 | $470,000 | -48.3% | 450,000 | -47.6% | 0.00% | – |
Q4 2019 | $909,000 | +7.4% | 858,000 | 0.0% | 0.00% | – |
Q3 2019 | $846,000 | -5.2% | 858,000 | 0.0% | 0.00% | – |
Q2 2019 | $892,000 | +1.1% | 858,000 | 0.0% | 0.00% | – |
Q1 2019 | $882,000 | +4.6% | 858,000 | +0.9% | 0.00% | – |
Q4 2018 | $843,000 | -6.9% | 850,000 | 0.0% | 0.00% | – |
Q3 2018 | $905,000 | – | 850,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |
LOOMIS SAYLES & CO L P | 901,591 | $69,512,000 | 0.09% |